AMD to invest in PsiQuantum as partnership expands quantum computing infrastructure
Quantum computing is drawing broader corporate and government backing as the sector pushes toward systems capable of handling problems beyond conventional computers. Against that backdrop, AMD plans to take an equity stake in PsiQuantum as the two companies deepen a partnership focused on infrastructure for utility-scale quantum machines.
Highlights
- AMD will make an undisclosed equity investment in PsiQuantum and expand their partnership to build infrastructure for utility-scale quantum computers.
- PsiQuantum's drug research workflows running on AMD hardware have achieved initial breakthroughs in simulating covalent inhibitors, supported by AMD’s CPUs, GPUs, and adaptive technology.
- The U.S. Commerce Department committed $100 million to PsiQuantum as part of a $2 billion CHIPS Act initiative investing in nine quantum computing firms.
Partnership broadens quantum infrastructure push
As reported by Reuters, AMD said on Thursday it plans to make an equity investment in PsiQuantum as part of an expanded partnership to build the computing infrastructure needed for utility-scale quantum computers. The companies do not disclose the size of AMD's planned investment.Under the agreement, AMD is set to provide CPUs, GPUs, adaptive computing technology and software, while PsiQuantum contributes its silicon photonics platform. The partners also plan to co-design computing infrastructure for quantum systems and develop applications that combine quantum computing with high-performance computing and artificial intelligence.
PsiQuantum's drug research technology is already running on AMD hardware, according to the companies, and they say it can produce more accurate results than existing methods. They add that combining PsiQuantum's workflow with AMD's GPU capabilities for large-scale simulation has delivered initial breakthrough results in simulating covalent inhibitors, a class of molecules used in oncology drug discovery.
Investor and policy support gathers pace
The transaction comes as investor interest in quantum computing grows, with companies and governments seeking systems that can solve scientific and commercial problems that are too complex for conventional computers. Recent advances in the technology are also fueling optimism about potential uses in drug discovery, financial modeling and cryptography.U.S. policy support is also expanding. The Commerce Department announced in May plans to take minority equity stakes in nine quantum computing companies under a $2 billion CHIPS Act investment program, including a $100 million deal with PsiQuantum.
We have previously detailed the AstraZeneca insitro deal to expand AI-driven drug discovery for liver and heart diseases.